Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on etanercept therapy in rheumatic diseases
Etanercept is a biologic medication used to treat various rheumatic diseases, including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. It works by inhibiting tumor necrosis factor (TNF), a protein involved in inflammation. By blocking TNF, Etanercept helps reduce inflammation, pain, and joint damage.
In rheumatoid arthritis, Etanercept has shown to significantly improve symptoms and slow disease progression. Patients experience relief from joint stiffness, swelling, and pain, leading to better physical function. It is often prescribed when other treatments, like methotrexate, do not provide sufficient results.
For psoriatic arthritis and ankylosing spondylitis, Etanercept also offers benefits by reducing joint inflammation and preventing further joint damage. It helps improve mobility and overall quality of life. However, long-term use requires regular monitoring, as it can increase the risk of infections and other side effects.
Overall, Etanercept provides an effective treatment option for patients with rheumatic diseases, especially when conventional therapies fall short.
Therefore, get an overall knowledge of etanercept therapy in rheumatic diseases. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.
2.
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
3.
Racial differences seen in epigenetic age acceleration in childhood cancer survivors
4.
ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer
5.
Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?
1.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
2.
The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025
3.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
4.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
5.
How to Prevent Tumor Lysis Syndrome in Cancer Patients
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
2.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
3.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
5.
Navigating the Complexities of Ph Negative ALL - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation